The FDA says it is confident that at-home rapid tests like those for COVID-19 are forthcoming for flu and RSV.
Feb. 2, 2023 – It’s easy these days to take an at-home COVID test when you have symptoms like a fever and sore throat. But when the test is negative, the next step toward diagnosis usually means leaving the comforts of home.
“We will be authorizing at-home flu and/or RSV tests that are multi-analyte with COVID,” an FDA official told WebMD. “I can’t tell you exactly when that would happen, but we are eager to do that.” “A couple of those have form factors that look like they should be fully at-home and over-the-counter,” he says “I’m optimistic that these will ultimately meet the performance bars that the FDA has.”
With pandemic culture propelling demand for at-home testing, many are recalling the 1970s era known as the sexual revolution, which centered on women’s autonomy over their own bodies. During that time, pregnancy testing moved from the clinical setting to the privacy of women’s homes. Both at-home COVID and pregnancy tests drew early concern from the medical community regarding test accuracy and potential for user error.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Flu, RSV on Decline, but COVID Deaths PersistRespiratory illness levels in the U.S. have declined so much in recent weeks that they are approaching numbers usually seen during non-flu season.
Les mer »
U.S. FDA removes COVID test requirements for Pfizer, Merck pillsThe U.S. Food and Drug Administration (FDA) on Wednesday removed the need for a positive test for COVID-19 treatments from Pfizer Inc and Merck & Co Inc .
Les mer »
A single-shot treatment to protect infants from RSV may be coming soonThe illness sends tens of thousands of babies to the hospital each year. If approved, the new injection would be the first broadly available prevention tool.
Les mer »
A single-shot treatment to protect infants from RSV may be coming soonRSV sends tens of thousands of babies to the hospital each year. If approved, a new injection to prevent it would be the first broadly available prevention tool.
Les mer »
A single-shot treatment to protect infants from RSV may be coming soonAstraZeneca says trial results show its single-dose treatment was nearly 75% effective at preventing severe infection in babies throughout an RSV season.
Les mer »
FDA revamping foods program to move past ‘constant turmoil’The head of the Food and Drug Administration announced an overhaul of the agency’s food safety and nutrition division, vowing that a new structure will better protect consumers and the U.S. food supply.
Les mer »